Immunotherapy for 'difficult to treat' lung cancer patients improves long-term survival

A two-for-one approach to boost melanoma immunotherapy

Researchers uncover potential biomarkers of positive response to immunotherapy

Study hints at how cancer immunotherapy can be safer